Capital Change Notice
Capital Change Notice
Updated as at June 2023
Section 1: Issuer information
Name of issuer Promisia Healthcare Limited
NZX ticker code PHL
Class of financial product Ordinary Shares/Unquoted
Restricted Share Units (RSUs)
ISIN (If unknown, check on NZX website) N/A
Currency NZD
Section 2: Capital change details
Number issued Shares issued: 60,000 shares
RSUs converted into ordinary
shares in PHL: 60,000 RSUs
Nominal value (if any) N/A
Issue price per security $0.283 (being the 20 business
day VWAP of PHL’s ordinary
shares prior to the vesting date
of the RSUs).
Nature of the payment (for example, cash or other
consideration)
Non-cash consideration
provided in the form of
services rendered by the
senior executive of PHL.
Amount paid up (if not in full) N/A
Percentage of total class of Financial Products issued
(calculated on the number of Financial Products of the Class,
excluding any Treasury Stock, in existence)
1
Percentage of shares issued:
0.11%
Percentage of RSUs
converted: 11.69%
For an issue of Convertible Financial Products or Options, the
principal terms of Conversion (for example the Conversion
price and Conversion date and the ranking of the Financial
Product in relation to other Classes of Financial Product) or the
Option (for example, the exercise price and exercise date)
N/A
Reason for issue and specific authority for
issue/acquisition/redemption/ (the reason for change must be
identified here)
The shares were issued upon
the conversion of RSUs in PHL
issued under the 2023
Promisia Healthcare Limited
Senior Executive Restricted
Share Plan Rules (RSU Plan
Rules)
Total number of Financial Products of the Class after the issue
(excluding Treasury Stock) and the total number of Financial
Products of the Class held as Treasury Stock after the
issue/acquisition/redemption.
Total number of shares on
issue: 52,603,617 shares
Total number of RSUs on
issue: 453,333 RSUs
1
The percentage is to be calculated immediately before the issue, acquisition, redemption or Conversion.
In the case of an acquisition of shares, whether those shares
are to be held as treasury stock
N/A
Specific authority for the issue, acquisition, or redemption,
including a reference to the rule pursuant to which the issue,
acquisition, or redemption is made
NZX Listing Rule 4.6.1 and in
accordance with the terms of
the individual’s letter of and the
RSU Plan Rules.
Terms or details of the issue, acquisition, or redemption (for
example: restrictions, escrow arrangements)
N/A
Date of issue/acquisition/redemption
2
14 November 2024
Section 3: Authority for this announcement and contact person
Name of person
authorised to make this announcement Francisco Rodriguez Ferrere
Contact person for this announcement Francisco Rodriguez Ferrere
Contact phone number +64 21 245 1801
Contact email address Francisco.rf@promisia.co.nz
Date of release through MAP
14 November 2024
2
Continuous issuers using this form in reliance on Rule 3.13.2, please indicate the period during which the relevant
issue/acquisition/redemptions were made (for example, 1 January 2019 to 31 January 2019).
Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.
Other issuers discussed similar conditions around this time
Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.
- FPH — Fisher & Paykel Healthcare Corporation Limited: Notification of Issue of Securities2024-08-30
“Capital Change Notice 30 August 2024 Issue of ordinary shares This notice is given under NZX Listing Rule 3.13.1 and relates to the issue of ordinary shares in Fisher & Paykel Healthcare Corporation Limited (“FPH”) in connection with one or more of FP…”
- FPH — Fisher & Paykel Healthcare Corporation Limited: Notification of Issue of Securities2024-09-10
“Capital Change Notice 10 September 2024 Issue of ordinary shares This notice is given under NZX Listing Rule 3.13.1 and relates to the issue of ordinary shares in Fisher & Paykel Healthcare Corporation Limited (“FPH”) in connection with one or more of…”
- FPH — Fisher & Paykel Healthcare Corporation Limited: Capital Change Notice - North America ESPP2025-01-05
“Capital Change Notice 6 January 2025 Issue of ordinary shares This notice is given under NZX Listing Rule 3.13.1 and relates to the issue of ordinary shares in Fisher & Paykel Healthcare Corporation Limited (“FPH”) in connection with one or more of FP…”